Copyright
©The Author(s) 2022.
World J Clin Oncol. Feb 24, 2022; 13(2): 71-100
Published online Feb 24, 2022. doi: 10.5306/wjco.v13.i2.71
Published online Feb 24, 2022. doi: 10.5306/wjco.v13.i2.71
Ref. | Yr | n1 | Design | Treatment | Conclusion |
Pieralli et al[223] | 2016 | 50 | Prospective Before-after study | 3 sessions of Fractional Microablative CO2 Laser every 30 d | The treatment seems to be feasible and effective |
Pagano et al[221] | 2016 | 26 | Observational retrospective study | 3 sessions of Fractional Microablative CO2 Laser every 30 d | The treatment seems to be effective and with good tolerance |
Gambacciani et al[218] | 2017 | 43 | Pilot before-after study | 3 sessions of Vaginal Erbium Laser every 30 d | The treatment seems to be effective |
Pagano et al[214] | 2018 | 82 | Observational retrospective study | 3 sessions of Fractional Microablative CO2 Laser every 30 d | The treatment seems to be effective |
Mothes et al[225] | 2018 | 16 | Retrospective study | 1 session of Vaginal Erbium YAG Laser | The treatment seems to be effective |
Pearson et al[222] | 2019 | 26 | Single-arm pilot study Before-After study | 3 sessions of Fractional Microablative CO2 Laser every 30 d | The treatment seems to improve sexual function and vaginal atrophy |
Areas et al[224] | 2019 | 24 | Open, prospective study | 3 sessions of Vaginal Erbium YAG Laser every 30 d | The treatment seems to improve sexual function and vaginal atrophy |
- Citation: Lubián López DM. Management of genitourinary syndrome of menopause in breast cancer survivors: An update. World J Clin Oncol 2022; 13(2): 71-100
- URL: https://www.wjgnet.com/2218-4333/full/v13/i2/71.htm
- DOI: https://dx.doi.org/10.5306/wjco.v13.i2.71